Atlas Trials

Effects of Varenicline on Smoking Lapse in Smokers With and Without Schizophrenia

Clinical trial NCT01850953 · COMPLETED

Trial details

NCT number
NCT01850953
Sponsor
Centre for Addiction and Mental Health
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
CravingSmokingSchizophrenia
Start date
2013-06-01
Primary completion
2015-05-01
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.